These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 21195041

  • 1. High-dose mesalazine treatment for ulcerative colitis patients who relapse under low-dose maintenance therapy.
    Yamamoto T, Umegae S, Matsumoto K.
    Dig Liver Dis; 2011 May; 43(5):386-90. PubMed ID: 21195041
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU, Bokemeyer B, Adamek H, Mross M, Vinter-Jensen L, Börner N, Silvennoinen J, Tan G, Pool MO, Stijnen T, Dietel P, Klugmann T, Vermeire S, Bhatt A, Veerman H.
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [Abstract] [Full Text] [Related]

  • 5. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M, Ikäheimo R, Pietiläinen T.
    Duodecim; 2003 Nov; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract] [Full Text] [Related]

  • 8. Encapsulated mesalamine granules (Apriso) for ulcerative colitis.
    Med Lett Drugs Ther; 2009 May 18; 51(1312):38-9. PubMed ID: 19448588
    [Abstract] [Full Text] [Related]

  • 9. Long-term oral plus topical mesalazine in frequently relapsing ulcerative colitis.
    Frieri G, Pimpo M, Galletti B, Palumbo G, Corrao G, Latella G, Chiaramonte M, Caprilli R.
    Dig Liver Dis; 2005 Feb 18; 37(2):92-6. PubMed ID: 15733520
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical trial: randomized-controlled clinical study comparing the efficacy and safety of a low-volume vs. a high-volume mesalazine foam in active distal ulcerative colitis.
    Eliakim R, Tulassay Z, Kupcinskas L, Adamonis K, Pokrotnieks J, Bar-Meir S, Lavy A, Mueller R, Greinwald R, Chermesh I, Gross V, International Salofalk Foam Study Group.
    Aliment Pharmacol Ther; 2007 Nov 01; 26(9):1237-49. PubMed ID: 17944738
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of two different daily dosages (2.4 vs. 1.2 g) of oral mesalazine in maintenance of remission in ulcerative colitis patients: 1-year follow-up study.
    Paoluzi OA, Iacopini F, Pica R, Crispino P, Marcheggiano A, Consolazio A, Rivera M, Paoluzi P.
    Aliment Pharmacol Ther; 2005 May 01; 21(9):1111-9. PubMed ID: 15854173
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Incà R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F.
    Dig Liver Dis; 2007 Apr 01; 39(4):329-37. PubMed ID: 17347061
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double blind, dose-response comparison of balsalazide (6.75 g), balsalazide (2.25 g), and mesalamine (2.4 g) in the treatment of active, mild-to-moderate ulcerative colitis.
    Levine DS, Riff DS, Pruitt R, Wruble L, Koval G, Sales D, Bell JK, Johnson LK.
    Am J Gastroenterol; 2002 Jun 01; 97(6):1398-407. PubMed ID: 12094857
    [Abstract] [Full Text] [Related]

  • 18. [Probiotics for prevention of ulcerative colitis recurrence: alternative medicine added to standard treatment?].
    Folwaczny C.
    Z Gastroenterol; 2000 Jun 01; 38(6):547-50. PubMed ID: 10923365
    [No Abstract] [Full Text] [Related]

  • 19. Maximizing patient adherence and clinical outcomes with mesalamine in mildly-to-moderately active ulcerative colitis.
    Lichtenstein GR, Rubin DT, Sabesin SM, Velayos FS, Vitat P.
    Rev Gastroenterol Disord; 2008 Jun 01; 8(1):21-30; quiz 31-2. PubMed ID: 18477967
    [Abstract] [Full Text] [Related]

  • 20. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
    Cohen RD, Woseth DM, Thisted RA, Hanauer SB.
    Am J Gastroenterol; 2000 May 01; 95(5):1263-76. PubMed ID: 10811338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.